Cargando…
Endothelin receptor antagonists for the treatment of diabetic nephropathy: A meta-analysis and systematic review
BACKGROUND: Diabetic nephropathy (DN) is the main cause of chronic kidney disease and end-stage renal disease worldwide. Although available clinical trials have shown that endothelin receptor (ER) antagonists may be a novel and beneficial drug for DN, no consistent conclusions regarding their suffic...
Autores principales: | Zhang, Li, Xue, Shuai, Hou, Jie, Chen, Guang, Xu, Zhong-Gao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7672789/ https://www.ncbi.nlm.nih.gov/pubmed/33269066 http://dx.doi.org/10.4239/wjd.v11.i11.553 |
Ejemplares similares
-
Interleukin-10-1082A/G Polymorphism and Diabetic Nephropathy: A Meta-Analysis
por: Peng, Xia, et al.
Publicado: (2015) -
The response of the Oxford classification to steroid in IgA nephropathy: a systematic review and meta-analysis
por: Yang, Pingping, et al.
Publicado: (2017) -
5-HT3 receptor antagonists for the prevention of postoperative shivering: a meta-analysis
por: Zhou, Chengmao, et al.
Publicado: (2016) -
Evaluation of crescent formation as a predictive marker in immunoglobulin A nephropathy: a systematic review and meta-analysis
por: Shao, Xue, et al.
Publicado: (2017) -
The reduction of concomitant glucocorticoids dosage following treatment with IL-1 receptor antagonist in adult onset Still’s disease. A systematic review and meta-analysis of observational studies
por: Ruscitti, Piero, et al.
Publicado: (2020)